2022 annual financial data
Atea Pharmaceuticals 2022 Operating margin
Atea Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was -67.98%.
Operating income was -130,650,000 USD and net income was -115,909,000 USD.
Operating cash flow was -120,982,000 USD.
Get free Atea Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 192,180,000 USD
- Operating income
- -130,650,000 USD
- Net income
- -115,909,000 USD
- Operating cash flow
- -120,982,000 USD